Our Recommendations
- WHO Global Essential Medicines (2025)
- WHO Antibiotic Categorization AWaRE (2025)
- People-centred approach to addressing antimicrobial resistance in human health (2023)
- Checklist for Core Elements of Hospital Antibiotic Stewardship Programs (2014)
- The Core Elements of Human Antibiotic Stewardship Programs in Resource-Limited Settings: National and Hospital Levels (2018)
New Publications
- WHO Global Essential Medicines (2025)
- WHO Antibiotic Categorization AWaRE (2025)
- Prevention and control of antimicrobial resistance in the Eastern Mediterranean Region – a progress report, 2024 (2024)
- Vaccines designed to reduce antimicrobial resistance (2024)
- Overuse of antibiotics for urinary tract infections in pregnant refugees, Lebanon (2024)
Filter
235
Featured
Recommendations
28
New Publications
40
Language
Document type
Guidelines
80
Studies & Reports
71
Manuals
18
Fact sheets
13
Situation Updates
11
Strategic & Response Plan
8
No document type
8
Infographics
7
Online Courses
6
Brochures
5
Resource Platforms
4
Training Material
2
Dashboards/Maps
2
Countries / Regions
South Africa
11
Africa
8
Global
5
Latin America and the Carribbean
5
Western and Central Europe
4
Kenya
3
Eastern Europe and Central Asia
3
Ethiopia
3
India
3
Nepal
2
Serbia
2
China
2
Nigeria
2
Senegal
2
Mozambique
2
Western Pacific Region
2
Vietnam
2
Indonesia
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Ukraine
1
Kazakhstan
1
Kyrgyzstan
1
Uzbekistan
1
Zimbabwe
1
Qatar
1
Armenia
1
Cambodia
1
Guinea-Bissau
1
Jordan
1
Congo, Democratic Republic of
1
West and Central Africa
1
United Kingdom
1
Argentina
1
Russia
1
Namibia
1
Egypt
1
Georgia
1
Mali
1
Angola
1
South Sudan
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Key Resources
28
Countries
20
Clinical Guidelines
4
Capacity Building
3
Women & Child Health
2
Pharmacy & Technologies
1
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
The toolkit provides guidance on where to get started, including the structures and resources that should be put in place at the national and health-care facility level, through a stepwise approach in low-resource settings. As the ultimate goal of an AMS programme is sustainable behaviour change in ...
Interactive Atlas
The GEHM series is an evidence-informed normative product of the WHO
Health and Migration Programme to inform policy-makers on migrationrelated public health priorities. These reviews aim to respond to policy questions identified as priorities by summarizing the best available evidence worldwide an...
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of antiviral and antibacterial agents from community phar...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
La vigilancia de la resistencia a los antimicrobianos (RAM) desempeña un papel importante en la detección temprana de cepas resistentes que revisten gran importancia para la salud pública, así como en la respuesta rápida a los brotes en los hospitales y en la comunidad. Los resultados de la vig...
Le présent document donne des indications supplémentaires pour un usage responsable et prudent des
antimicrobiens chez les animaux élevés pour l’alimentation humaine. II convient de le lire en conjonction
avec le Code d’usages international recommandé pour le contrôle de l'utilisation de...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
Antimicrobial resistance (AMR) as a serious public health threat was globally acknowledged by WHO in 2015, through the launch of the Global Action Plan (GAP). With a limited number of new antibiotics in the developmental pipeline, many countries are in the process of establishing strategies for anti...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
